Global Injectable Drug Delivery System 麻豆原创 Research Report 2024

Publication ID:

PB505244223

Publication Date:

May 3, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Injectable Drug Delivery System market was valued at US$ 486680 million in 2023 and is anticipated to reach US$ 884500 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Injectable Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Drug Delivery System.
Report Scope
The Injectable Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Drug Delivery System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Novartis
Boston Scientific
3M
Roche
Pfizer
Johnson & Johnson
BD
AstraZeneca
Baxter
Bayer
TheraJect
Segment by Type
Conventional Devices
Self Injecting Devices
Others
Segment by Application
Hospital
Clinic
Personal
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Injectable Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Injectable Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Injectable Drug Delivery System 麻豆原创 Overview
1.1 Product Overview and Scope of Injectable Drug Delivery System
1.2 Injectable Drug Delivery System Segment by Type
1.2.1 Global Injectable Drug Delivery System 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Conventional Devices
1.2.3 Self Injecting Devices
1.2.4 Others
1.3 Injectable Drug Delivery System Segment by Application
1.3.1 Global Injectable Drug Delivery System 麻豆原创 Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Personal
1.3.5 Others
1.4 Global Injectable Drug Delivery System 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Injectable Drug Delivery System Revenue 2019-2030
1.4.2 Global Injectable Drug Delivery System Sales 2019-2030
1.4.3 Global Injectable Drug Delivery System 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Injectable Drug Delivery System 麻豆原创 Competition by Manufacturers
2.1 Global Injectable Drug Delivery System Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Injectable Drug Delivery System Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Injectable Drug Delivery System Average Price by Manufacturers (2019-2024)
2.4 Global Injectable Drug Delivery System Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injectable Drug Delivery System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injectable Drug Delivery System, Product Type & Application
2.7 Injectable Drug Delivery System 麻豆原创 Competitive Situation and Trends
2.7.1 Injectable Drug Delivery System 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Injectable Drug Delivery System Players 麻豆原创 Share by Revenue
2.7.3 Global Injectable Drug Delivery System 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injectable Drug Delivery System Retrospective 麻豆原创 Scenario by Region
3.1 Global Injectable Drug Delivery System 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Injectable Drug Delivery System Global Injectable Drug Delivery System Sales by Region: 2019-2030
3.2.1 Global Injectable Drug Delivery System Sales by Region: 2019-2024
3.2.2 Global Injectable Drug Delivery System Sales by Region: 2025-2030
3.3 Global Injectable Drug Delivery System Global Injectable Drug Delivery System Revenue by Region: 2019-2030
3.3.1 Global Injectable Drug Delivery System Revenue by Region: 2019-2024
3.3.2 Global Injectable Drug Delivery System Revenue by Region: 2025-2030
3.4 North America Injectable Drug Delivery System 麻豆原创 Facts & Figures by Country
3.4.1 North America Injectable Drug Delivery System 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Injectable Drug Delivery System Sales by Country (2019-2030)
3.4.3 North America Injectable Drug Delivery System Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Injectable Drug Delivery System 麻豆原创 Facts & Figures by Country
3.5.1 Europe Injectable Drug Delivery System 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Injectable Drug Delivery System Sales by Country (2019-2030)
3.5.3 Europe Injectable Drug Delivery System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Drug Delivery System 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Injectable Drug Delivery System 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Injectable Drug Delivery System Sales by Country (2019-2030)
3.6.3 Asia Pacific Injectable Drug Delivery System Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Injectable Drug Delivery System 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Injectable Drug Delivery System 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Injectable Drug Delivery System Sales by Country (2019-2030)
3.7.3 Latin America Injectable Drug Delivery System Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injectable Drug Delivery System 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Drug Delivery System 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Injectable Drug Delivery System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Injectable Drug Delivery System Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injectable Drug Delivery System Sales by Type (2019-2030)
4.1.1 Global Injectable Drug Delivery System Sales by Type (2019-2024)
4.1.2 Global Injectable Drug Delivery System Sales by Type (2025-2030)
4.1.3 Global Injectable Drug Delivery System Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Injectable Drug Delivery System Revenue by Type (2019-2030)
4.2.1 Global Injectable Drug Delivery System Revenue by Type (2019-2024)
4.2.2 Global Injectable Drug Delivery System Revenue by Type (2025-2030)
4.2.3 Global Injectable Drug Delivery System Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Injectable Drug Delivery System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Injectable Drug Delivery System Sales by Application (2019-2030)
5.1.1 Global Injectable Drug Delivery System Sales by Application (2019-2024)
5.1.2 Global Injectable Drug Delivery System Sales by Application (2025-2030)
5.1.3 Global Injectable Drug Delivery System Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Injectable Drug Delivery System Revenue by Application (2019-2030)
5.2.1 Global Injectable Drug Delivery System Revenue by Application (2019-2024)
5.2.2 Global Injectable Drug Delivery System Revenue by Application (2025-2030)
5.2.3 Global Injectable Drug Delivery System Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Injectable Drug Delivery System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Injectable Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Injectable Drug Delivery System Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Injectable Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Injectable Drug Delivery System Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 3M
6.3.1 3M Corporation Information
6.3.2 3M Description and Business Overview
6.3.3 3M Injectable Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 3M Injectable Drug Delivery System Product Portfolio
6.3.5 3M Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Injectable Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Injectable Drug Delivery System Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Injectable Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Injectable Drug Delivery System Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Injectable Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Johnson & Johnson Injectable Drug Delivery System Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 BD
6.6.1 BD Corporation Information
6.6.2 BD Description and Business Overview
6.6.3 BD Injectable Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BD Injectable Drug Delivery System Product Portfolio
6.7.5 BD Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Injectable Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 AstraZeneca Injectable Drug Delivery System Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Baxter
6.9.1 Baxter Corporation Information
6.9.2 Baxter Description and Business Overview
6.9.3 Baxter Injectable Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Baxter Injectable Drug Delivery System Product Portfolio
6.9.5 Baxter Recent Developments/Updates
6.10 Bayer
6.10.1 Bayer Corporation Information
6.10.2 Bayer Description and Business Overview
6.10.3 Bayer Injectable Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bayer Injectable Drug Delivery System Product Portfolio
6.10.5 Bayer Recent Developments/Updates
6.11 TheraJect
6.11.1 TheraJect Corporation Information
6.11.2 TheraJect Injectable Drug Delivery System Description and Business Overview
6.11.3 TheraJect Injectable Drug Delivery System Sales, Revenue and Gross Margin (2019-2024)
6.11.4 TheraJect Injectable Drug Delivery System Product Portfolio
6.11.5 TheraJect Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Drug Delivery System Industry Chain Analysis
7.2 Injectable Drug Delivery System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Drug Delivery System Production Mode & Process
7.4 Injectable Drug Delivery System Sales and 麻豆原创ing
7.4.1 Injectable Drug Delivery System Sales Channels
7.4.2 Injectable Drug Delivery System Distributors
7.5 Injectable Drug Delivery System Customers
8 Injectable Drug Delivery System 麻豆原创 Dynamics
8.1 Injectable Drug Delivery System Industry Trends
8.2 Injectable Drug Delivery System 麻豆原创 Drivers
8.3 Injectable Drug Delivery System 麻豆原创 Challenges
8.4 Injectable Drug Delivery System 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Novartis
Boston Scientific
3M
Roche
Pfizer
Johnson & Johnson
BD
AstraZeneca
Baxter
Bayer
TheraJect

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.